NMS Labs offers comprehensive umbilical cord drug screening for 16 major classes of drugs including 57 drugs and metabolites. As the premier esoteric laboratory, NMS Labs’ unparalleled drug trending monitoring and surveillance program uniquely makes us as a leading authority in the identification and reporting of newborn drug exposure. Our state-of-the-art laboratory includes clinical, forensic and research facilities staffed by more than 350 highly trained professionals. Our scope of tests, accuracy of results, scientific expertise & innovation provide neonatal nurses and professionals the confidence that their newborn patients have been accurately screened and in a timely manner. For more information on NMS Labs and to learn more about our neonatal umbilical cord testing, please visit us at https://www.nmslabs.com/solutions/newborn-toxicology.
